Zika Virus Vaccines: Challenges and Perspectives
Open Access
Abstract
Zika virus is an arbovirus that has rapidly spread within the Americas since 2014, presenting a variety of clinical manifestations and neurological complications resulting in congenital malformation, microcephaly, and possibly, in male infertility. These significant clinical manifestations have led investigators to develop several candidate vaccines specific to Zika virus. In this review we describe relevant targets for the development of vaccines specific for Zika virus, the development status of various vaccine candidates and their different platforms, as well as their clinical progression.Keywords
This publication has 102 references indexed in Scilit:
- Rational Design of a Flavivirus Vaccine by Abolishing Viral RNA 2′- O MethylationJournal of Virology, 2013
- The Requirement for Potent Adjuvants To Enhance the Immunogenicity and Protective Efficacy of Protein Vaccines Can Be Overcome by Prior Immunization with a Recombinant AdenovirusThe Journal of Immunology, 2011
- Probable Non–Vector-borne Transmission of Zika Virus, Colorado, USAEmerging Infectious Diseases, 2011
- Flavivirus Cell Entry and Membrane FusionViruses, 2011
- Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain IIIJournal of General Virology, 2010
- DNA vaccines: ready for prime time?Nature Reviews Genetics, 2008
- Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007Emerging Infectious Diseases, 2008
- A structural perspective of the flavivirus life cycleNature Reviews Microbiology, 2005
- Yellow fever vaccineBMJ, 2002
- Flavivirus Infection Enhancement in Macrophages: an Electron Microscopic Study of Viral Cellular EntryJournal of General Virology, 1985